Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1 h post-load glucose levels? (Q38998224)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 January 2017

Language	Label	Description	Also known as
English	Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1 h post-load glucose levels?	scientific article published on 25 January 2017

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1 h post-load glucose levels? (English)

1 reference

Europe PubMed Central

8 September 2017

9

object named as

Angela Chetrit

0 references

object named as

Rachel Dankner

10

0 references

author name string

Michael Bergman

1

1 reference

Europe PubMed Central

8 September 2017

Ram Jagannathan

2

1 reference

Europe PubMed Central

8 September 2017

Martin Buysschaert

3

1 reference

Europe PubMed Central

8 September 2017

Jose Luis Medina

4

1 reference

Europe PubMed Central

8 September 2017

Mary Ann Sevick

5

1 reference

Europe PubMed Central

8 September 2017

Karin Katz

6

1 reference

Europe PubMed Central

8 September 2017

Brenda Dorcely

7

1 reference

Europe PubMed Central

8 September 2017

Jesse Roth

8

1 reference

Europe PubMed Central

8 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

25 January 2017

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

8 September 2017

55

1 reference

Europe PubMed Central

8 September 2017

3

1 reference

Europe PubMed Central

8 September 2017

697-701

1 reference

Europe PubMed Central

8 September 2017

https://scigraph.springernature.com/pub.10.1007/s12020-017-1236-2

0 references

Lifetime direct medical costs of treating type 2 diabetes and diabetic complications

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Behavioral strategies in diabetes prevention programs: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Lifestyle Interventions for Patients With and at Risk for Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study from a real world health care setting

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

The 1-hour post-load glucose level is more effective than HbA1c for screening dysglycemia

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

An elevated 1-h post- load glucose level during the oral glucose tolerance test detects prediabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Inadequacies of absolute threshold levels for diagnosing prediabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

The Early Diabetes Intervention Program--is early actually late?

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Prediabetes and associated disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Dysglycemia and long-term mortality: observations from the Israel study of glucose intolerance, obesity and hypertension.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Long-term changes and variability in diabetes risk factors prior to the development of impaired glucose homeostasis.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Mode of onset of type 2 diabetes from normal or impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

What is the best predictor of future type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Plasma glucose concentration and prediction of future risk of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

1-Hour plasma glucose in obese youth

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

One-hour plasma glucose as a predictor of the development of Type 2 diabetes in Japanese adults

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

One-hour post-load plasma glucose level during the OGTT predicts dysglycemia: Observations from the 24year follow-up of the Israel Study of Glucose Intolerance, Obesity and Hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

One-hour postload plasma glucose concentration in people with normal glucose homeostasis predicts future diabetes mellitus: a 12-year community-based cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Predictability of 1-h postload plasma glucose concentration: A 10-year retrospective cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

One-hour postload plasma glucose levels are associated with kidney dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Progression to Type 2 Diabetes Characterized by Moderate Then Rapid Glucose Increases

1 reference

https://api.crossref.org/works/10.1007%2FS12020-017-1236-2

21 January 2018

Adapting the Diabetes Prevention Program lifestyle intervention for delivery in the community: the YMCA model

1 reference

https://pubmed.ncbi.nlm.nih.gov/28124259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

β-Cell Function and Insulin Sensitivity in Normal Glucose-Tolerant Subjects Stratified by 1-Hour Plasma Glucose Values.

1 reference

https://pubmed.ncbi.nlm.nih.gov/28124259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/28124259

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12020-017-1236-2

1 reference

Europe PubMed Central

8 September 2017

1 reference

Europe PubMed Central

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38998224&oldid=1640428058"